Search details
1.
An Audit to Evaluate Vancomycin Therapeutic Drug Monitoring in a Neonatal Intensive Care Unit.
Ther Drug Monit
; 44(5): 651-658, 2022 10 01.
Article
in English
| MEDLINE | ID: mdl-35383737
2.
Restoration of type I interferon expression by heme and related tetrapyrroles through inhibition of NS3/4A protease.
J Infect Dis
; 208(10): 1653-63, 2013 Nov 15.
Article
in English
| MEDLINE | ID: mdl-23901085
3.
Multicenter phase II trial of Camrelizumab combined with Apatinib and Eribulin in heavily pretreated patients with advanced triple-negative breast cancer.
Nat Commun
; 13(1): 3011, 2022 05 31.
Article
in English
| MEDLINE | ID: mdl-35641481
4.
Biliverdin inhibits hepatitis C virus nonstructural 3/4A protease activity: mechanism for the antiviral effects of heme oxygenase?
Hepatology
; 52(6): 1897-905, 2010 Dec.
Article
in English
| MEDLINE | ID: mdl-21105106
5.
Zinc protoporphyrin binding to telomerase complexes and inhibition of telomerase activity.
Pharmacol Res Perspect
; 9(6): e00882, 2021 12.
Article
in English
| MEDLINE | ID: mdl-34747573
6.
Hepatitis C virus core protein enhances Telomerase activity in Huh7 cells.
J Med Virol
; 82(2): 239-48, 2010 Feb.
Article
in English
| MEDLINE | ID: mdl-20029802
7.
The ceRNA Network Has Potential Prognostic Value in Clear Cell Renal Cell Carcinoma: A Study Based on TCGA Database.
Biomed Res Int
; 2020: 4830847, 2020.
Article
in English
| MEDLINE | ID: mdl-32685491
8.
Metalloprotoporphyrin Inhibition of HCV NS3-4A Protease: Structure-Activity Relationships.
Drug Des Devel Ther
; 14: 757-771, 2020.
Article
in English
| MEDLINE | ID: mdl-32158194
9.
Heme oxygenase-1 suppresses hepatitis C virus replication and increases resistance of hepatocytes to oxidant injury.
Hepatology
; 48(5): 1430-9, 2008 Nov.
Article
in English
| MEDLINE | ID: mdl-18972446
10.
Oncogenic AKAP9-BRAF fusion is a novel mechanism of MAPK pathway activation in thyroid cancer.
J Clin Invest
; 115(1): 94-101, 2005 Jan.
Article
in English
| MEDLINE | ID: mdl-15630448
11.
Delineation, functional validation, and bioinformatic evaluation of gene expression in thyroid follicular carcinomas with the PAX8-PPARG translocation.
Clin Cancer Res
; 12(7 Pt 1): 1983-93, 2006 Apr 01.
Article
in English
| MEDLINE | ID: mdl-16609007
12.
HCV Induces Telomerase Reverse Transcriptase, Increases Its Catalytic Activity, and Promotes Caspase Degradation in Infected Human Hepatocytes.
PLoS One
; 12(1): e0166853, 2017.
Article
in English
| MEDLINE | ID: mdl-28056029
13.
Molecular classification of papillary thyroid carcinoma: distinct BRAF, RAS, and RET/PTC mutation-specific gene expression profiles discovered by DNA microarray analysis.
Oncogene
; 24(44): 6646-56, 2005 Oct 06.
Article
in English
| MEDLINE | ID: mdl-16007166
14.
Prevalence of RET/PTC rearrangements in thyroid papillary carcinomas: effects of the detection methods and genetic heterogeneity.
J Clin Endocrinol Metab
; 91(9): 3603-10, 2006 Sep.
Article
in English
| MEDLINE | ID: mdl-16772343
15.
Correlation between genetic alterations and microscopic features, clinical manifestations, and prognostic characteristics of thyroid papillary carcinomas.
Am J Surg Pathol
; 30(2): 216-22, 2006 Feb.
Article
in English
| MEDLINE | ID: mdl-16434896
16.
High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma.
Cancer Res
; 63(7): 1454-7, 2003 Apr 01.
Article
in English
| MEDLINE | ID: mdl-12670889
17.
Induction and expression of betaig-h3 in pancreatic cancer cells.
Biochim Biophys Acta
; 1588(1): 1-6, 2002 Oct 09.
Article
in English
| MEDLINE | ID: mdl-12379307
18.
Dose-dependent generation of RET/PTC in human thyroid cells after in vitro exposure to gamma-radiation: a model of carcinogenic chromosomal rearrangement induced by ionizing radiation.
J Clin Endocrinol Metab
; 90(4): 2364-9, 2005 Apr.
Article
in English
| MEDLINE | ID: mdl-15671095
19.
BRAF copy number gains in thyroid tumors detected by fluorescence in situ hybridization.
Endocr Pathol
; 16(2): 99-105, 2005.
Article
in English
| MEDLINE | ID: mdl-16199894
20.
BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas.
J Clin Endocrinol Metab
; 88(11): 5399-404, 2003 Nov.
Article
in English
| MEDLINE | ID: mdl-14602780